GU Research Network, LLC is a clinical research site located in Omaha, Nebraska, United States 68130.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
GU Research Network, LLC has participated in 5 clinical trials.
Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer, Bone Metastases.
Sponsors: Bayer, Ajjai Alva, MD, Bavarian Nordic.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
GU Research Network, LLC has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GU Research Network, LLC has 5 clinical trials on record. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer, Bone Metastases.
Yes — GU Research Network, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.